Medanta performs Rare Paediatric Kidney Transplant on a 12 year old boy

Published On 2016-03-13 06:16 GMT   |   Update On 2016-03-13 06:16 GMT

Gurgaon: Kidney transplantation is considered an optimal therapy for all children with end stage renal disease with there is better longevity, quality of life and cost-effectiveness in comparison to long-term maintenance dialysis. Due to a severe shortage of suitable cadaveric donors, most paediatric patients receive a kidney from their living relatives. “If an appropriate living related...

Login or Register to read the full article
Gurgaon: Kidney transplantation is considered an optimal therapy for all children with end stage renal disease with there is better longevity, quality of life and cost-effectiveness in comparison to long-term maintenance dialysis. Due to a severe shortage of suitable cadaveric donors, most paediatric patients receive a kidney from their living relatives. “If an appropriate living related donor is not available, a child may have to wait for a considerable period of time for a cadaveric donor. In such circumstances, blood group ABO incompatibility was regarded as a major obstacle in screening potential living donors”, said Dr Vijay Kher, Chairman, Nephrology, Medanta - The Medicity.

A 12-year-old boy presented to Medanta with kidney failure, was started on haemodialysis. The options of renal transplantation were discussed. The blood group of the patient was B+, and no family member had the compatible blood group, despite an extensive search for 6 months. The patient’s mother had blood group AB+. Even though the mother had a different blood group, the child received renal transplant with mother as the donor, with a designed desensitization and immunosuppressive protocol. This is the first time in India that a child has got a kidney transplant across the blood group barrier. “The child underwent a kidney transplant in Medanta, and is currently completely normal, and leading a normal school life” said Dr Sidharth Sethi, Consultant, Paediatric Nephrology, Medanta - The Medicity.

This is to emphasize to the general public and doctors that ABO incompatibility does not always mean loss of hope for children with end stage renal disease.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News